DJIA 17,856.78 -278.94 -1.54%
NASDAQ 4,927.37 -55.44 -1.11%
S&P 500 2,071.26 -29.78 -1.42%
market minute promo


289.92 -5.78 (-1.95%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ACT $289.92 -1.95%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $295.29
Previous Close $295.70
Daily Range $289.26 - $295.86
52-Week Range $184.71 - $298.23
Market Cap $77.2B
P/E Ratio -39.85
Dividend (Yield) $0.00 (0.0%)
Volume 3,071,255
Average Daily Volume 3,181,266
Current FY EPS $17.50




Drug Makers

ACTAVIS (ACT) Description

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Website:

News & Commentary

Billionaire George Soros Just Bought These 3 Stocks: Should You?

Hedge fund guru George Soros gobbled up these three healthcare stocks in the fourth-quarter. Should average investors follow in his footsteps?

Ironwood Commences Dosing in Phase I Study on IW-1973 - Analyst Blog

Mallinckrodt to Acquire Ikaria, Expand into Hospital Market - Analyst Blog

Bernard Horn's Most Heavily Weighted Stocks

Actavis' Avycaz Delivers A One-Two Punch To Superbugs

Benzinga's Top Initiations

Thanks For The Corporate Bond Bubble, Fed

UBS Makes Big Changes to Equity Focus List For March

Wall Street Breakfast: The Interest Rate Cuts Continue

Actavis' Xydalba Granted Marketing Authorisation in Europe - Analyst Blog

Actavis' Xydalba Granted Marketing Authorisation in Europe - Analyst Blog

Endo International Shares Upbeat After Positive Q4 Earnings Report

See More ACT News...

ACT's Top Competitors

ACT $289.92 (-1.95%)
Current stock: ACT
JNJ $100.11 (-2.35%)
Current stock: JNJ
PFE $33.97 (-1.45%)
Current stock: PFE
NVS $97.46 (-1.51%)
Current stock: NVS